-
Article
Open AccessCost of start-up activities to implement a community-level opioid overdose reduction intervention in the HEALing Communities Study
Communities That HEAL (CTH) is a novel, data-driven community-engaged intervention designed to reduce opioid overdose deaths by increasing community engagement, adoption of an integrated set of evidence-based ...
-
Article
Open AccessRacial/ethnic differences in receipt of naloxone distributed by opioid overdose prevention programs in New York City
We evaluated racial/ethnic differences in the receipt of naloxone distributed by opioid overdose prevention programs (OOPPs) in New York City (NYC).
-
Article
Open AccessThe effects of COVID-19 on New York State’s Drug User Health Hubs and syringe service programs: a qualitative study
Syringe service programs (SSPs) deliver critical harm reduction services to people who inject drugs (PWID). Some SSPs in New York State received enhanced funding to provide additional services to combat opioid...
-
Article
Open AccessCorrection: M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
-
Article
Open AccessResponding to a surge in overdose deaths: perspectives from US syringe services programs
US overdose deaths have reached a record high. Syringe services programs (SSPs) play a critical role in addressing this crisis by providing multiple services to people who use drugs (PWUD) that help prevent ov...
-
Article
Open AccessM2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
Opioid use is escalating in North America and comes with a multitude of health consequences, including HIV and hepatitis C virus (HCV) outbreaks among persons who inject drugs (PWID). HIV pre-exposure prophyla...
-
Article
Impact of Removing Medicaid Fee-for-Service Hepatitis C Virus (HCV) Treatment Restrictions on HCV Provider Experience with Medicaid Managed Care Organizations in New York City
Immediately after the approval of direct-acting antiviral medications for the treatment of hepatitis C virus (HCV) in 2013, state Medicaid programs limited access to these expensive treatments based on liver d...
-
Article
Open AccessHarmonizing healthcare and other resource measures for evaluating economic costs in substance use disorder research
Standardization and harmonization of healthcare resource utilization data can improve evaluations of the economic impact of treating people with substance use disorder (SUD), including reductions in use of exp...
-
Article
Structural Design and Data Requirements for Simulation Modelling in HIV/AIDS: A Narrative Review
Born out of a necessity for fiscal sustainability, simulation modeling is playing an increasingly prominent role in setting priorities for combination implementation strategies for HIV treatment and prevention...
-
Article
Open AccessImproving HIV service delivery for people who inject drugs in Kazakhstan: study protocol for the Bridge stepped-wedge trial
People who inject drugs (PWID) in Kazakhstan face many barriers to HIV testing as well as to accessing HIV care, to retention in HIV care, and to initiating and adhering to anti-retroviral treatment (ART). Nee...
-
Article
Open AccessStudy protocol for a pragmatic trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) model for engaging patients in opioid use disorder treatment
Treatment for opioid use disorder (OUD) is highly effective, yet it remains dramatically underutilized. Individuals with OUD have disproportionately high rates of hospitalization and low rates of addiction tre...
-
Article
Open AccessClosing the gaps in opioid use disorder research, policy and practice: conference proceedings
Drug overdose deaths involving opioids have surged in recent years and the economic cost of the opioid epidemic is estimated to be over $500 billion annually. In the midst of calls for declaring a national eme...
-
Article
Open AccessCriminal justice measures for economic data harmonization in substance use disorder research
The consequences of substance use disorders (SUDs) are varied and broad, affecting many sectors of society and the economy. Economic evaluation translates these consequences into dollars to examine the net eco...
-
Article
Open AccessRationale, design, and methodology of a trial evaluating three models of care for HCV treatment among injection drug users on opioid agonist therapy
People who inject drugs (PWID) constitute 60% of the approximately 5 million people in the U.S. infected with hepatitis C virus (HCV). Treatment of PWID is complex due to addiction, mental illness, poverty, ho...
-
Article
Open AccessThe structural and health policy environment for delivering integrated HIV and substance use disorder treatments in Puerto Rico
HIV prevalence in Puerto Rico is nearly twice that of the mainland United States, a level that was substantially fueled by injection drug use. Puerto Rico has a longstanding history of health provision by the ...
-
Article
Open AccessOn-site bundled rapid HIV/HCV testing in substance use disorder treatment programs: study protocol for a hybrid design randomized controlled trial
More than 1.2 million people in the United States are living with human immunodeficiency virus (HIV), and 3.2 million are living with hepatitis C virus (HCV). An estimated 25 % of persons living with HIV also ...
-
Chapter
Considerations for Develo** Applied Health Policy Models: The Example of HIV Treatment Expansion in Resource-Limited Settings
This chapter describes steps for develo** health policy models. The discussion begins with considerations for identifying a research question and develo** a model conceptual framework. It next provides gui...
-
Article
Open AccessThe cost of antiretroviral therapy in Haiti
We determined direct medical costs, overhead costs, societal costs, and personnel requirements for the provision of antiretroviral therapy (ART) to patients with AIDS in Haiti.
-
Article
Open AccessDoes higher cost mean better quality? evidence from highly-regarded adolescent drug treatment programs
We conducted a survey to examine whether reimbursement levels are associated with the quality of adolescent substance use treatment programs in the United States. Between March and September 2005, telephone an...
-
Article
Offers of Hepatitis C Care Do Not Lead to Treatment
Since 2002, clinicians have been encouraged to offer chronic hepatitis C virus (HCV) treatment to patients with injection drug use histories. We conducted 69 baseline and 35 follow-up interviews between Septem...
